myUpchar प्लस+ सदस्य बनें और करें पूरे परिवार के स्वास्थ्य खर्च पर भारी बचत,केवल Rs 99 में -


Eptifibatide Information

Eptifibatide Benefits & Uses

Eptifibatide is used to treat the following -

Eptifibatide Dosage & How to Take

This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.

Find the right dosage based on disease and age

Log in to view medicine dosage

Ingredients of Eptifibatide


Eptifibatide Side Effects

Based on research, the following side effects have been observed when Eptifibatide is used -

  1. Inflammation of a vein
  2. Anemia
  3. Bleeding
  4. Decreased blood pressure
  5. Flushing
  6. Gastrointestinal discomfort
  7. Heart Attack
  8. Altered heart rate
  9. Heart related issues
  10. Decreased white blood cell count (neutrophils)
  11. Shock
  12. Tachycardia
  13. Abdominal Pain Mild
  14. Back Pain Mild
  15. Bleeding Gums Mild
  16. Confusion
  17. Blurred vision
  18. Dizziness सामान्य
  19. Headache सामान्य
  20. Blood or red colored urine
  21. Nausea or vomiting

Eptifibatide Related Warnings

Is the use of Eptifibatide safe for pregnant women?

No research has been done regarding the safety of Eptifibatide for pregnant women. Therefore, it cannot be said if Eptifibatide is safe during pregnancy.


Is the use of Eptifibatide safe during breastfeeding?

In the absence of any scientific study of side effects of Eptifibatide for breastfeeding women, information on safety of Eptifibatide is unavailable.


What is the effect of Eptifibatide on the Kidneys?

Very few cases of side effects of Eptifibatide on kidney have been reported.


What is the effect of Eptifibatide on the Liver?

You may experience side effects on your liver after taking Eptifibatide. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.


What is the effect of Eptifibatide on the Heart?

Eptifibatide has very mild side effects on the heart.


Severe Interaction of Eptifibatide with Other Drugs

Eptifibatide should not be taken with following medicines due to severe side effects it may cause to patients -

Eptifibatide Contraindications

If you are suffering from any of the following diseases, you should not take Eptifibatide unless your doctor advises you to do so -

  1. Bleeding
  2. Stroke
  3. Trauma
  4. Kidney Disease
  5. Thrombocytopenia and ITP

Frequently asked Questions about Eptifibatide

Is this Eptifibatide habit forming or addictive?

No, you do not get addicted to Eptifibatide.

Is it safe to drive or operate heavy machinery when consuming?

Yes, you can comfortably use machinery or drive after taking Eptifibatide since it will not make you feel sleepy.


Is it safe?

Yes, but you should take Eptifibatide only as per your doctor's advice.

Safe, but take only on Doctor's advise

Is it able to treat mental disorders?

Eptifibatide is unable to treat or cure mental disorders.


Eptifibatide Interactions with Food and Alcohol

Interaction between Food and Eptifibatide

information is not available on the interaction of any foods with Eptifibatide, due to a lack of research on this.


Interaction between Alcohol and Eptifibatide

Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Eptifibatide.

This medicine data has been created by -
Md Saadullah
M.Pharma, Pharmacy
3 Years of Experience
View Doctor Profile
Vikas Chauhan
B.Pharma, Pharmacy
2 Years of Experience
View Doctor Profile

Do you or someone in your family take Eptifibatide? Please do a survey and help others


  1. US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Integrilin® (eptifibatide)
  2. KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 631
  3. April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 512-514